glutathione s-transferase u8 π: a potential role in antitumor therapy | DDDT Roles for glutathione transferases in

In 2004, Alimta in combination with another chemo drug, cisplatin, received approval by the Food and Drug Administration (FDA) to treat malignant pleural mesothelioma

Glutathione carbon dots as an intracellular reactive oxygen species scavenger for reducing cisplatin-induced ototoxicity

Yet, amidst all the hype, some ingredients stand out due to their scientifically-backed benefits

Cetuximab demonstrated a strong cytotoxic activity on A431 cells after 120 h of incubation, and synergism was shown by immunoliposomes containing cetuximab and 5-FU [277]

The regulatory landscape changeswhat was accessible in one year may not be accessible the next, and vice versa

In comparison, Tapi demonstrated significantly stronger agonistic activity, achieving a ten-fold enhancement